Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor-Reference-Cited by-同舟云学术

Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor

Published:2005-05 Issue:5 Volume:16 Page:716-725
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Colleoni M.,Li S.,Gelber R.D.,Coates A.S.,Castiglione-Gertsch M.,Price K.N.,Lindtner J.,Rudenstam C.-M.,Crivellari D.,Collins J.,Pagani O.,Simoncini E.,Thürlimann B.,Murray E.,Forbes J.,Eržen D.,Holmberg S.,Veronesi A.,Goldhirsch A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/16/5/716/352497/mdi163.pdf

Reference33 articles.

1. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials;Lancet,1998

2. for the International Breast Cancer Study Group. Overhauling the breast cancer overview: are subsets subversive?;Coates;Lancet Oncol,2002

3. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer;Goldhirsch;J Clin Oncol,2001

4. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer;Goldhirsch;J Clin Oncol,2003

5. Long Term Tamoxifen For Breast Cancer;Osborne,1994

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis;The Breast;2017-06

2. A nation-wide multicenter 10-year (1999-2008) retrospective study of chemotherapy in Chinese breast cancer patients;Oncotarget;2017-03-22

3. Novel Translational Research of Neo-adjuvant Endocrine Therapy;Personalized Treatment of Breast Cancer;2016

4. Management of patients with hormone receptor–positive breast cancer with visceral disease: challenges and treatment options;Cancer Management and Research;2015-01

5. Ovarian function preservation with GnRH agonist in young breast cancer patients: Does it impede the effect of adjuvant chemotherapy?;The Breast;2014-10